Source link : https://www.newshealth.biz/health-news/magnetic-seeds-guidewires-for-breast-cancer-localization/ TOPLINE: Paramagnetic seeds work just as well as standard guidewires for breast tumor localization and are easier for surgeons, radiologists, and operating room planners to use. METHODOLOGY: Paramagnetic seeds have shown…
Category: Health
Source link : https://www.newshealth.biz/health-news/expert-highlights-biologics-in-the-pipeline-for-eczema/ In the opinion of David Rosmarin, MD, the approval of dupilumab in 2017 for the treatment of moderate to severe, resistant atopic dermatitis (AD) marked an inflection point in dermatology. “Dupilumab…
Source link : https://www.newshealth.biz/health-news/mortality-still-significant-in-high-risk-pe-despite-advances/ TOPLINE: 1 in 5 patients with high-risk pulmonary embolism (PE) and more than 2 in 5 with catastrophic PE with hemodynamic collapse die in the hospital, a large contemporary analysis showed….
Source link : https://www.newshealth.biz/health-news/prescription-drugs-sold-online-without-robust-checks/ More than 1,600 pills were bought by a BBC reporter who entered false information online without challenge. Source link : https://www.bbc.co.uk/news/health-67714023?at_medium=RSS&at_campaign=KARANGA Author : Publish date : 2024-01-05 00:10:15 Copyright for syndicated…
Source link : https://www.newshealth.biz/health-news/ozempic-similar-drugs-not-linked-to-increased-pancreatic-cancer-risk/ People with type 2 diabetes taking an anti-diabetes medication such as semaglutide did not have an increased risk of pancreatic cancer, a new study found. These drugs, known as GLP-1 receptor…
Source link : https://www.newshealth.biz/health-news/neurologic-disabilities-linked-to-long-covid-risks/ Some long COVID symptoms were more likely for persons with multiple sclerosis (MS), traumatic brain injury (TBI), or spinal cord injury (SCI), a retrospective cohort study found. After having COVID-19, such…
Source link : https://www.newshealth.biz/health-news/study-assuages-fears-of-pancreatic-cancer-risk-with-glp-1-receptor-agonists/ Several years after initiating treatment, GLP-1 receptor agonist users didn’t have a pancreatic cancer safety signal, a historical cohort study reported. Compared with basal insulin users, those on a GLP-1 receptor…